Biomedical Sciences
Global

Biomedical Sciences Experts

Gary

Chief Financial Officer
Management
Nabriva Therapeutics
Austria

Biography

Gary   has over 25 years of financial leadership experience in the pharmaceutical and biopharmaceutical industries, most recently as Chief Financial Officer and EVP at Synergy Pharmaceuticals. From 2009-2015, Mr. Sender served as Senior Vice President, Finance at Shire plc. supporting its Specialty Pharmaceuticals business and subsequently its Global Commercial businesses. He was responsible for financial management and support of all commercial areas of Shire’s $6 billion Specialty Pharmaceutical and Rare Disease businesses, with an emphasis on resource allocation, financial forecasting, business cases and M&A. Prior to joining Shire, he was the founding CFO of Tengion – a biotechnology company in the field of Regenerative Medicine. Mr. Sender spent 15 years in a number of leadership roles within Merck, including Investor Relations, M&A Finance, Treasury and Divisional Financial Management. Mr. Sender holds a bachelor’s degree in Finance and Information Systems from Boston University and a master’s degree in Industrial Administration (MBA) with a concentration in Finance from Carnegie-Mellon University.

Research Interest

Biopharmaceutics. 

Global Experts from Austria

Global Experts in Subject

Share This Profile
Recommended Conferences
  • 5th Annual Congress and Medicare Expo on Trauma & Critical Care March 05-06, 2019 Amsterdam, Netherlands

    March 05-06, 2019 Amsterdam, Netherlands

  • 2nd Annual Summit on Cell Therapy and Regenerative Medicine November 9-10, 2018 Atlanta, Georgia, USA

    November 9-10, 2018 Atlanta, USA

View more
Relevant Topics